|Last Price||Today's Change||52-Week Range||Trading Volume|
|131.26||5.07 (+4.02%)||84.41 - 137.50||3.7 million (Above Avg)|
Market data as of 4:00PM 07/02/15. Quotes are delayed by at least 15 min.
ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacaftor) - the First Medicine to Treat the Underlying Cause of Cystic Fibrosis for People Ages 12 and Older with Two Copies of the F508del Mutation
07/02/2015 1:46 PM ET
Sangeeta N. Bhatia, M.D., Ph.D., Joins Vertex Board of Directors
06/18/2015 4:01 PM ET